X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

McFadden, Chief Judge. We granted C. W.’s application for discretionary review of a superior court order that reinstated the decision of the Division of Family and Children Services of the Department of Human Services (“DFCS”) to include C. W.’s name on the central child abuse registry for prenatal abuse because of her use of marijuana while pregnant. See OCGA §§ 49-5-180 (5) (2018), 49-5-181 (a) (2018). C. W. argues that under the language of the governing statutes, marijuana is not a “controlled substance,” and so a mother’s use of marijuana during pregnancy does not amount to prenatal abuse. To its credit, DFCS concedes that C. W. is correct. We agree, so we reverse. The central child abuse registry, which is also known as the Child Protective Services Information System, is a statutory system that provides for the establishment and maintenance of a central registry containing information about “substantiated” cases of child abuse. See OCGA §§ 49-5-180 – 49-5-187. The Act [establishing the registry] requires that DFCS investigate reports of child abuse and, if the abuse investigator finds by a preponderance of the evidence that an act of child abuse occurred, information must be added to the registry about the abuse, the abuser, the child victim, and the child’s guardian. See OCGA §§ 49-5-182, 49-5-183. . . . OCGA § 49-5-183 requires that DFCS must notify an alleged abuser when his or her name is added to the registry. See OCGA § 49-5-183 (a). The alleged abuser may then request an evidentiary hearing before an administrative law judge (“ALJ”) by submitting a written request for a hearing to DFCS within ten days after receiving the notice. See OCGA § 49-5-183 (a) and (c). . . . The ALJ makes the final “administrative determination regarding whether, based on a preponderance of evidence, there was child abuse committed by the alleged child abuser to justify the investigator’s determination of a substantiated case.” OCGA § 49-5-183 (d). If not, the ALJ must order the alleged abuser’s name removed from the registry. OCGA § 49-5-183 (e). Ga. Dept. of Human Svcs. v. Steiner, 303 Ga. 890, 890-891 (I) (815 SE2d 883) (2018). DFCS placed C. W.’s name on the child abuse registry based on its determination that she had committed child abuse by unlawfully using a controlled substance while she was pregnant. The child abuse investigator stated in the Notice of Inclusion mailed to C. W. that C. W. was “substantiated for child endangerment as a result of prenatal abuse. [C. W.] exposed [her daughter,] B. W.[,] (newborn) to chronic abuse of a controlled substance, specifically marijuana. At the time of B. W.’s birth . . . THC [(the common abbreviation for tetrahydrocannabinol)] was positive in B. W.’s meconium.” The investigator testified that C. W. had told him that, at the suggestion of a doctor and a midwife, she had used marijuana to help alleviate nausea and vomiting. C. W. petitioned for a hearing under OCGA § 49-5-183 (c) to challenge the inclusion of her name on the child abuse registry. An administrative law judge ordered DFCS to remove C. W.’s name because under the plain language of the statutes at issue, marijuana is not a controlled substance, so a mother’s use of marijuana while pregnant does not amount to prenatal abuse. DFCS appealed the administrative law judge’s decision to the superior court. The superior court reversed because THC, the substance identified in the infant’s meconium, is a controlled substance under OCGA § 16-13-21 (4). C. W. then filed her application for discretionary appeal. The Act establishing the child abuse registry provides that child abuse includes “endangering a child,” which can include “prenatal abuse” as defined in OCGA § 15-11-2. OCGA §§ 19-7-5 (b) (4) (C) & (b) (6.1) (D); 49-5-180 (4). OCGA § 15-11-2 defines “prenatal abuse” as: exposure to chronic or severe use of alcohol or the unlawful use of any controlled substance, as such term is defined in Code Section 161321, which results in: (A) Symptoms of withdrawal in a newborn or the presence of a controlled substance or a metabolite thereof in a newborn’s body, blood, urine, or meconium that is not the result of medical treatment; or (B) Medically diagnosed and harmful effects in a newborn’s physical appearance or functioning. OCGA § 15112 (56). So as relevant here, prenatal abuse that amounts to endangering a child requires proof that, among other things, a pregnant woman used a controlled substance as defined in OCGA § 16-13-21. OCGA § 16-13-21 defines “controlled substance” as “a drug, substance, or immediate precursor in Schedules I through v. of Code Sections 161325 through 161329 and Schedules I through v. of 21 CFR Part 1308.” OCGA § 16-13-21 (4). Thus, under the plain language of the statute — as C. W. argues, the administrative law judge found, and DFCS concedes — a drug is a “controlled substance” as defined in OCGA § 161321 only if it is listed as such in both Georgia and federal schedules. Federal Schedule I includes marijuana, see 21 USC § 812 Sch. I (c) (10); 21 CFR § 1308.11 (d) (23), but Georgia’s schedules do not. See OCGA §§ 161325 through 16-13-29. Since marijuana is not a controlled substance as defined by OCGA § 161321, a mother’s use of marijuana while pregnant does not amount to prenatal abuse. The superior court ruled that because THC was present in C. W.’s urine and B. W.’s meconium and there was evidence that C. W. consumed marijuana while pregnant, C. W. exposed B. W. to a controlled substance, THC (which is listed on both Georgia and federal schedules. See OCGA § 16-13-25 (3) (P); 21 USC § 812 Sch. I (c) (17); 21 CFR § 1308.11 (d) (31)). But, as DFCS concedes, our law distinguishes marijuana from THC. See, e.g., OCGA § 161321 (16) (“‘Marijuana’ means all parts of the plant of the genus Cannabis . . . .”); OCGA § 161330 (a), (j) (separately addressing “any controlled substance” and “marijuana”). So there was no evidence on which the superior court could have based that finding. There was no evidence that C. W. used any drug other than marijuana, such as synthetic THC, that could have resulted in the presence of THC in B. W.’s meconium, and, as detailed above, the evidence that C. W. used marijuana is not sufficient to substantiate “prenatal abuse” under the applicable statutes. For these reasons, the superior court erred by reinstating the decision of DFCS to include C. W.’s name on the central child abuse registry, and we reverse. We do not reach C. W.’s other claims of error. Judgment reversed. McMillian, P.J., and Senior Appellate Judge Herbert E. Phipps concur.

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

More From ALM

With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
View Now
Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
View Now
Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
View Now
May 01, 2025
Atlanta, GA

The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.


Learn More
December 02, 2024 - December 03, 2024
Scottsdale, AZ

Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!


Learn More
December 11, 2024
Las Vegas, NV

This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.


Learn More

We are seeking two attorneys with a minimum of two to three years of experience to join our prominent and thriving education law practice in...


Apply Now ›

Description: Fox Rothschild has an opening in the New York office for a Real Estate Litigation Associate with three to six years of commerci...


Apply Now ›

Downtown NY property and casualty defense law firm seeks a Litigation Associate with 3+ years' experience to become a part of our team! You ...


Apply Now ›